ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 109 for:    fibromyalgia | Recruiting, Not yet recruiting, Available Studies | Interventional Studies

Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia (PRFM-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03133455
Recruitment Status : Recruiting
First Posted : April 28, 2017
Last Update Posted : April 28, 2017
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens

Brief Summary:

Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.

The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.


Condition or disease Intervention/treatment Phase
Fibromyalgia Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM. Not Applicable

Study Type : Interventional
Estimated Enrollment : 80 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia
Actual Study Start Date : September 16, 2015
Estimated Primary Completion Date : December 30, 2017
Estimated Study Completion Date : December 30, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fibromyalgia

Arm Intervention/treatment
Patient with Fibromyalgia Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.




Primary Outcome Measures :
  1. Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire [ Time Frame: 1 hour ]
    Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • FM Criteria of the American College of Rheumatology ACR 1990.
  • Major Patients
  • free and informed consent signed
  • stable treatment for at least one month
  • Native French speaker
  • Patient covered by health insurance.

Exclusion Criteria:

  • Patient deprived of liberty or protected major (under guardianship or curatorship)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03133455


Contacts
Contact: Eric SERRA, Dr +33322668820 serra.eric@chu-amiens.fr

Locations
France
CHU Amiens Picardie Recruiting
Amiens, Picardie, France, 80054
Contact: Eric SERRA, Dr    +33322668820    serra.eric@chu-amiens.fr   
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens

Responsible Party: Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier: NCT03133455     History of Changes
Other Study ID Numbers: PI2015_843_0024
First Posted: April 28, 2017    Key Record Dates
Last Update Posted: April 28, 2017
Last Verified: April 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Centre Hospitalier Universitaire, Amiens:
Rumination

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases